Barclays’s NextCure NXTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31K | Hold |
5,627
| – | – | ﹤0.01% | 4022 |
|
|
2025
Q1 | $32K | Hold |
5,627
| – | – | ﹤0.01% | 3982 |
|
|
2024
Q4 | $52K | Hold |
5,627
| – | – | ﹤0.01% | 3948 |
|
|
2024
Q3 | $92K | Hold |
5,627
| – | – | ﹤0.01% | 3763 |
|
|
2024
Q2 | $107K | Sell |
5,627
-2
| -0% | -$38 | ﹤0.01% | 3341 |
|
|
2024
Q1 | $150K | Hold |
5,629
| – | – | ﹤0.01% | 3477 |
|
|
2023
Q4 | $77K | Hold |
5,629
| – | – | ﹤0.01% | 3772 |
|
|
2023
Q3 | $87K | Hold |
5,629
| – | – | ﹤0.01% | 3373 |
|
|
2023
Q2 | $121K | Hold |
5,629
| – | – | ﹤0.01% | 3330 |
|
|
2023
Q1 | $100K | Sell |
5,629
-1
| -0% | -$18 | ﹤0.01% | 3530 |
|
|
2022
Q4 | $95K | Sell |
5,630
-44
| -0.8% | -$742 | ﹤0.01% | 3488 |
|
|
2022
Q3 | $187K | Hold |
5,674
| – | – | ﹤0.01% | 3129 |
|
|
2022
Q2 | $320K | Sell |
5,674
-400
| -7% | -$22.6K | ﹤0.01% | 2863 |
|
|
2022
Q1 | $354K | Buy |
6,074
+78
| +1% | +$4.55K | ﹤0.01% | 3000 |
|
|
2021
Q4 | $432K | Sell |
5,996
-201
| -3% | -$14.5K | ﹤0.01% | 2584 |
|
|
2021
Q3 | $501K | Buy |
6,197
+2,992
| +93% | +$242K | ﹤0.01% | 2609 |
|
|
2021
Q2 | $309K | Buy |
3,205
+32
| +1% | +$3.09K | ﹤0.01% | 2706 |
|
|
2021
Q1 | $381K | Sell |
3,173
-456
| -13% | -$54.8K | ﹤0.01% | 2808 |
|
|
2020
Q4 | $474K | Sell |
3,629
-239
| -6% | -$31.2K | ﹤0.01% | 2339 |
|
|
2020
Q3 | $407K | Buy |
3,868
+3,040
| +367% | +$320K | ﹤0.01% | 2407 |
|
|
2020
Q2 | $213K | Buy |
828
+341
| +70% | +$87.7K | ﹤0.01% | 2777 |
|
|
2020
Q1 | $216K | Sell |
487
-803
| -62% | -$356K | ﹤0.01% | 2508 |
|
|
2019
Q4 | $872K | Buy |
1,290
+1,136
| +738% | +$768K | ﹤0.01% | 2387 |
|
|
2019
Q3 | $56K | Sell |
154
-676
| -81% | -$246K | ﹤0.01% | 3649 |
|
|
2019
Q2 | $138K | Buy |
+830
| New | +$138K | ﹤0.01% | 3416 |
|